Status:

COMPLETED

A Study of Botulinum Toxin Type A Treatment of Wrinkles in Asian

Lead Sponsor:

Shanghai Jiao Tong University School of Medicine

Conditions:

Botulinum Toxin, Type A

Eligibility:

All Genders

18+ years

Phase:

EARLY_PHASE1

Brief Summary

OBJECTIVES: The aim of this randomized, parallel-group, double-blinded controlled multicenter clinical trial is to determine the proper dosage of botulinum toxin type A in Asian, and provide evidence-...

Detailed Description

This was a self-reported, randomized, parallel-group, double-blinded controlled multicenter clinical trial. It was conducted in Wuhan, Shanghai, and Dongguan, China, at the plastic and reconstructive ...

Eligibility Criteria

Inclusion

  • 1\. Chinese males or females aged over 18 years old who want to accept medical removal of the wrinkle;
  • 2\. Noticeable symmetrical wrinkles on both sides of the face (grade 1-4 on the 5-grade Wrinkles Severity Rating Scale);
  • 3\. Female patients must take a pregnancy test to prove they are not pregnant, and they are also asked to use a method of contraception 30 days before inclusion into the group and to use a reliable method of contraception throughout the entire study;
  • 4\. Patients should not accept other forms of cosmetic intervention and agree to refrain from participation in any other clinical trials that may interrupt the study.

Exclusion

  • 1\. The wrinkle severity of any site or both sites are either grade 0 or 5 on the 5-grade Wrinkle Severity Rating Scale.
  • 2\. The presence of facial hair that may influence the observation of wrinkle severity;
  • 3\. The area of injection had an apparent acne scar, active inflammation, infection, cancer or premalignancy, or untreated wound;
  • 4\. Patients who had facial plastic surgery, tissue transplant, silica gel, liposome (fat) injection, or other permanent or semipermanent dermal filler;
  • 5\. Patients who had any type of Botox injection in the last year or were injected more than 3 times.

Key Trial Info

Start Date :

February 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 2 2017

Estimated Enrollment :

250 Patients enrolled

Trial Details

Trial ID

NCT05324839

Start Date

February 1 2014

End Date

March 2 2017

Last Update

April 12 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.